TrialThoracic cancer2021

Effectiveness of anlotinib in patients with small-cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.